MetaTOC stay on top of your field, easily

17{beta}-Estradiol Mediates Superior Adaptation Of Right Ventricular Function To Acute Strenuous Exercise In Female Rats With Severe Pulmonary Hypertension

, , , , , , , , , , ,

AJP Lung Cellular and Molecular Physiology

Published online on

Abstract

17β-estradiol (E2) exerts protective effects on right ventricular (RV) function in pulmonary arterial hypertension (PAH). Since acute exercise-induced increases in afterload may lead to RV dysfunction in PAH, we sought to determine whether E2 allows for superior RV adaptation after an acute exercise challenge. We studied echocardiographic, hemodynamic, structural and biochemical markers of RV function in male and female rats with sugen/hypoxia (SuHx)-induced pulmonary hypertension, as well as in ovariectomized (OVX) SuHx females with or without concomitant E2 repletion (75 μg/kg/d) immediately after 45 min of treadmill running at 75% of individually-determined maximal aerobic capacity (75% VO2 reserve). Compared to males, intact female rats exhibited higher stroke volume and cardiac indices, a strong trend for better RV compliance, and less pronounced increases in indexed total pulmonary resistance. OVX abrogated favorable RV adaptations, whereas E2 repletion after OVX markedly improved RV function. E2's effects on pulmonary vascular remodeling were complex and less robust than its RV effects. Post-exercise hemodynamics in females with endogenous or exogenous E2 were similar to hemodynamics in non-exercised controls, whereas OVX rats exhibited more severely altered post-exercise hemodynamics. E2 mediated inhibitory effects on RV fibrosis and attenuated increases in RV collagen I/III ratio. Pro-apoptotic signaling, eNOS phosphorylation and autophagic flux markers were affected by E2 depletion and/or repletion. Markers of impaired autophagic flux correlated with endpoints of RV structure and function. Endogenous and exogenous E2 exerts protective effects on RV function measured immediately after an acute exercise challenge. Harnessing E2's mechanisms may lead to novel RV-directed therapies.